secwatch.observer — SEC 8-K summary
======================================

Issuer:     AtaiBeckley Inc. (ATAI)
CIK:        0002081043
Form:       8-K
Filed at:   2026-08-31T20:38:46+00:00
Accession:  0001140361-26-035091
Event type: m_and_a
Sentiment:  positive
Materiality: 0.55
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

ATAI's merger with Eli Lilly clears US HSR and UK CMA; Australian waiting period expires Sept 10
--------------------------------------------------------------------------------

- US HSR waiting period for ATAI-Eli Lilly merger expired at 11:59 p.m. ET on Aug 28, 2026.
- UK CMA responded Aug 21, 2026, indicating no further questions on the merger briefing.
- Australian ACCC determined Aug 27, 2026, merger may proceed subject to 14-day waiting period expiring Sept 10, 2026 at 10:00 a.m. ET.
- Merger agreement dated July 15, 2026; ATAI to become wholly owned subsidiary of Eli Lilly.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2081043/000114036126035091/0001140361-26-035091-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2081043/000114036126035091/ef20081348_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-26-035091

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer